participants/materials, setting, methods: The PMR was calculated according to the number of embryos transferred and other demographic and treatment-related factors. Perinatal deaths were defined as the number of fetal deaths (stillbirths) plus the number of neonatal deaths (deaths that occur before 28 days after birth).
Introduction
Fetal, neonatal and perinatal mortality are important indicators of maternal care and maternal health, and outcome measures for monitoring pregnancy and childbirth (World Health Organization, 2007) . These indicators are particularly relevant for babies born following assisted reproductive technology (ART) treatment, as these births have been associated with the higher rates of prematurity, small for gestational age, multiple births and congenital anomalies when compared with spontaneous conceptions (Fretts, 2005; Lisonkova et al., 2010; Wang et al., 2010) . There are at least four reasons for monitoring perinatal health applicable to ART: continuing risks to mothers and babies; inequality in perinatal health; changing technology resulting in new risks and the need for more comprehensive statistics to inform policy and planning of ART-related health care (EURO-PERISTAT, 2008) .
Babies born following ART treatment in Australia and New Zealand have a higher risk of perinatal mortality compared with all births in their respective countries (Laws et al., 2010; Perinatal and Maternal Mortality Review Committee, 2010; Wang et al., 2010) . In 2008, the perinatal mortality rate (PMR) for babies born after ART treatment in Australia and New Zealand was 16.2 per 1000 births compared with 10.2 and 10.6 per 1000 births among all babies born in Australia and New Zealand, respectively (Laws et al., 2010; Perinatal and Maternal Mortality Review Committee, 2010) . This excess mortality among ART babies likely reflects known risk factors for perinatal mortality such as older maternal age, nulliparity, medical comorbidities, multiple pregnancy and recurrent miscarriage (Fretts, 2005; Lisonkova et al., 2010; Wang et al., 2010) , which are more prevalent among women giving birth after ART compared with spontaneous conceptions (Schieve et al., 2007; Pelkonen et al., 2010; Tandberg et al., 2010) .
However, in recent years there has been a decline in perinatal mortality among babies born after ART in Australia and New Zealand from 24.7 per 1000 births following ART treatment in 1999 to 16.2 per 1000 births following ART treatment in 2008 (Hurst and Lancaster, 2001; Wang et al., 2010) . This mirrored the increase in the proportion of single embryo transfer (SET) from 14.2% in 1999 to 67.8% in 2008 and the accompanying 13.7% point reduction in the multiple delivery rate from 22.1% in 2000 to 8.4% in 2008 (Hurst and Lancaster, 2001 Wang et al., 2010) . This study investigates perinatal mortality (fetal and neonatal deaths ending before 28 completed days after birth) in Australia and New Zealand following ART treatment. The hypothesis is that SET is associated with a reduction in PMR when compared with double embryo transfer (DET).
Methods

Data source
Data were obtained from the Australian and New Zealand Assisted Reproduction Database (ANZARD), a population-based cohort data collection. The ANZARD is a census of all initiated ART treatment cycles undertaken in Australia and New Zealand. Items on ANZARD are collected annually, in a de-identified format, from all fertility centers within Australia and New Zealand. The ANZARD includes information on both the ART treatment (oocyte pick-up, fertilization procedure, use of thawed embryos, blastocyst culture, embryo transfer and donation of gametes or embryos) and resulting pregnancy and birth outcomes (birth status, gestational age and birthweight).
Follow-up of pregnancy and birth outcomes were by the fertility centers, with the patient or clinician and/or the use of routine data from the relevant health department. Information on pregnancy and neonatal outcomes was missing from ,1% of clinical pregnancies recorded in ANZARD for the study period. There are no data on the timing of fetal death, that is whether it was an antepartum or intrapartum death. There are no data of cause of death or late termination of pregnancy (at 20 weeks or more gestation).
Study population
This population study included all births following embryo transfer cycles that occurred during the period from 1 January 2004 to 31 December 2008. The study population consisted of 50 328 babies from 44 959 deliveries, following ART treatment, during the study period. Of the 50 328 babies, 70 (0.14% of all records) did not have a birth outcome recorded and were excluded as no further information was available. The remaining 50 258 babies were included in the final analysis.
Study factors and potential confounders
Patient's demographic and treatment factors in ANZARD were validated according to the clinical record. The number of embryos transferred (single, double (DET) or ≥3 embryos) was the main study factor. The following demographic and treatment factors were treated as potential confounders and included in the analysis. (i) Women's age at the time of ART treatment was classified as ,30, 30 -34, 35 -39 or ≥40 years; (ii) the cause of infertility was either male factor only, female factor only (tubal disease, endometriosis or other female diagnosis), combined malefemale (both male and female factors were diagnosed), an unexplained cause of infertility (neither male nor female factors were diagnosed) or not stated; (iii) parity was the number of previous pregnancies of ≥20 weeks gestation and was classed as either nulliparous (no previous pregnancy) or parous (at least one previous pregnancy); (iv) the fertilization procedure was in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI) or not stated; (v) the stage of embryo development was either cleavage stage or blastocyst stage; (vi) the type of transferred embryo was fresh or thawed and (vii) the type of treatment was non-donor (autologous) or donor; and (viii) the year of treatment was also included as potential confounder.
Main outcome measures
Birth was defined as the expulsion or extraction from its mother of a product of conception of 20 or more completed weeks of gestation or 400 g or more birthweight. Fetal death was defined as a death prior to complete expulsion or extraction from its mother of a product of conception of 20 or more completed weeks of gestation or 400 g or more of birthweight (Laws et al., 2010) . Neonatal death was defined as death that occurs in the neonatal period (0 -27 completed days) after a live birth (Laws et al., 2010) . A perinatal death was either a fetal or neonatal death.
Sample size and study power
To significantly differentiate the PMR of 10 per 1000 births for SET births from the PMR of 15 per 1000 births for DET births with a study power of 80% ( a ¼ 0.05), a total sample size of 16 144 births was required. The study population of a census of 50 328 births following ART treatment in 2004 -2008 has increased the study power to 99%.
Statistical analysis
The above definitions of birth and perinatal period were used to calculate the rates of fetal, neonatal and perinatal mortality. All rates were expressed per 1000 births with 95% confidence interval (CI) calculated using Poisson distribution. Univariate and multivariate generalized linear models for singletons and generalized estimated equation models for all births were conducted to estimate the risk of perinatal mortality by demographic and treatment factors. Factors included in the multivariate model were woman's age, cause of infertility, parity, year of treatment, number of embryos transferred, fertilization procedures, stage of embryo development and type of embryos and type of treatment. Risk ratio (RR), adjusted risk ratio (ARR) and 95% CI were calculated. Data were analyzed using SPSS, version 19.0 (SPSS Inc., Chicago, IL).
Ethics
Ethics approval for this study was granted by the Human Research Ethics Advisory Panel of the University of New South Wales (2010_7_55). Approval from the Fertility Society of Australia was received to use the data. Table I presents the number and rate of fetal, neonatal and perinatal deaths following ART in Australia and New Zealand stratified by plurality and number of embryos transferred. Of the 813 perinatal deaths, 630 were fetal deaths (stillbirths) and 183 were neonatal deaths. Twins accounted for half of neonatal deaths and one-third of perinatal deaths. The overall PMR was 16.2 per 1000 births. Births following DET had higher rates of fetal death (14.1 per 1000 births), neonatal death (5.1 per 1000 live births) and perinatal death (19.1 per 1000 births) than births following SET (11.0 per 1000 births, 2.3 per 1000 live births and 13.2 per 1000 births, respectively). Twins had significantly higher rates of fetal, neonatal and perinatal mortality than singletons (Table I) .
Results
Table II details the differences in PMRs between births following SET and DET stratified by demographic factors. The PMR of births to women aged 30-34 years following DET was significantly higher than the PMR of births following SET (RR 1.73, 95% CI: 1.34-2.24). DET births to women having female factor only infertility had a significantly higher PMR than SET births (RR 1.68, 95% CI: 1.28 -2.19). For births to both nulliparous and parous women, DET was related to a more than 40% increased risk of perinatal mortality than SET (RR 1.43, 95% CI: 1.19 -1.72 and RR 1.44, 95% CI: 1.04 -2.01, respectively).
DET births had significantly higher PMR than SET births regardless of fertilization procedures and stage of embryo development (Table III) . Of births following fresh embryo transfers, DET births had 58% increased risk of perinatal mortality than SET births (RR 1.58, 95% CI: 1.32 -1.90). Of births following autologous ART treatment, the PMR was significantly higher for births following DET than those following SET (RR 1.45, 95% CI: 1.24 -1.70) ( Table III) . Table IV presents the estimated risk of perinatal mortality of DET births compared with SET births stratified by plurality and transfers of fresh or thawed embryos. The risk of perinatal mortality for all births following DET was 53% higher than those following SET (ARR 1.53, 95% CI: 1.29 -1.80). Singletons following transfers of fresh DET had 1.3 times increased risk of perinatal mortality than those following transfers of fresh SET (RR 1.27, 95% CI: 1.02-1.57). Of births following transfer of thawed embryos, there was no increased risk of perinatal mortality for DET births compared with SET births regardless of plurality.
Twins following DET had half the risk of perinatal mortality than twins following SET (ARR 0.48, 95% CI: 0.32 -0.72) due to monozygosity following SET (Table IV) . There were 52 perinatal deaths from 32 multiple deliveries following SET, including 51 perinatal deaths from 31 twin deliveries and one death from a triplet delivery. Of the 51 perinatal deaths following twin delivery, 40 were deaths of both twins (20 sets of twins). Of the 20 sets of twins who died during the perinatal period, 14 sets of twins had the same sex and, for six sets of twins, the sex was not stated but assumed as identical. Perinatal mortality rate (per 1000 births) was calculated using all births as denominator. RR, risk ratio.
the same 5-year period (Laws et al., 2010) . The higher perinatal mortality for ART births reflects in part the treatment practice of multiple embryo transfer with only 78.8% of babies born as singletons following ART compared with 96.8% for all births (Laws et al., 2010) . This population-based national study provides evidence of the benefits of the practice of SET in Australia and New Zealand on perinatal mortality. It confirms that, for ART births, the most critical factor for perinatal mortality is the number of embryos transferred. It shows that SET is associated with a lower rate of perinatal mortality compared with DET, even when a singleton results from DET. The PMR for births following DET was 44% higher at 19.1 per 1000 DET births when compared with births following SET. If the PMR for SET is applied to DET births for the duration of the study, an estimated 144 additional perinatal deaths would have been potentially prevented. Further when compared with DET, SET had a significantly lower perinatal mortality across ART treatment factors except for transfers of thawed embryos and twin gestation.
Other studies have provided evidence that transfers of fresh or thawed embryos intersecting with number of embryos transferred impacts the perinatal outcomes (Shih et al., 2008; Wang et al., 2009) . This study found a significantly lower risk of perinatal mortality for births following fresh SETs than for births following fresh DETs (RR 1.58, 95% CI: 1.32 -1.90). The PMR was not significantly lower for births following thawed SETs than for those following thawed DETs (RR 1.10, 95% CI: 0.83 -1.47). It is important to note that two-thirds of births following ART in the study period were following transfers of fresh embryos and half of births following fresh embryo transfers were by DETs. The higher PMR following fresh DET indicates that transfer of two embryos in a fresh cycle has an increased public health impact with greater risk to mothers (Campbell and Templeton, 2004) , poorer birth outcomes (Wang et al. 2009 ) and greater economic and social burden on the healthcare system .
This study found a non-significant higher PMR for singleton births following fresh cycles when compared with thaw cycles. This trend of higher PMR was exaggerated for twin births with almost double the PMR for twins following fresh compared with thaw cycles. This explanation is consistent with a Swedish registry study which found a lower rate of twinning after frozen ART cycles compared with fresh cycles in conjunction with a lower rate of infant mortality after frozen IVF cycles (Källén et al., 2005) . The authors postulated embryo viability as an explanation for differences in the perinatal outcomes. Twin gestations following SET had more than twice the PMR of twin gestations following DET and were associated with over four times the risks of perinatal death compared with SET singletons. However, this finding must be contextualized as only 3.9% of births following SET were twins and of those one in 20 births is a perinatal death compared with just over one in 40 for twins following DET. The significantly lower PMR among twins with two embryos transferred is the likely result of dizygotic twins having lower perinatal mortality than monozygotic twins. The monozygotic twins in this study are likely to arise primarily from SET and from transfer at the blastocyst stage (Boulet et al., 2008; Vitthala et al., 2009) . Although this study does not have information on zygosity, of the 14 sets of twins where both twins died and sex was known, all were monozygotic. Encouragingly recent research using the Swedish registry has found no evidence of an increased rate of monozygotic twinning after ART for embryo transfers ( twinning (Finnstrom et al., 2011) . Further research is needed to determine which pregnancies and ART treatment factors are at greater risk of twin gestation following SET to minimize the risk of twinning and associated increased risks of congenital malformations and perinatal mortality (Halliday et al., 2010) . Dizygotic twin pregnancies have been a common outcome internationally of ART treatment associated with the practice of transferring more than one embryo per treatment cycle (Centers for Disease Control and Prevention 2010; de Mouzon et al., 2010; Wang et al., 2010; Gunby et al., 2011; Human Fertilisation and Embryology Authority, 2010) . Mortality data from this study provides further evidence that DET, from a public health and healthy start in life perspective, should no longer be first-line management for the great majority of ART patients. The formal adoption of a policy of SET through the Reproductive Technology Accreditation Committee introducing guidelines specific to SET for Australia and New Zealand fertility centers in 2003 has seen a 19.5% increase in SET resulting in a 15.6% point reduction in twin gestations (Reproductive Technology Accreditation Committee, 2005; Wang et al., 2010) . This is consistent with the trends seen in Sweden and Finland where there has been a decline in poorer perinatal outcomes associated with the adoption of SET (Källén et al., 2010 , Pelkonen et al., 2010 , Sazonova et al., 2011 . A longer period of follow-up is needed to determine the association between the implementation of a policy of SET and a reduction of overall perinatal mortality of ART births in Australia and New Zealand (Wang et al., 2006; .
The strength of this study is that it used 5 years of National Australian and New Zealand data with 10 000 births per year which minimized the effects of random variation and maximized the stability and reliability of the mortality rates. With all registry studies, there is the potential for information biases associated with differential ascertainment of the deaths from the births. This is particularly relevant for Australia and New Zealand where there is probable underascertainment of the deaths due to the follow-up being largely a clinic-based activity rather than death data being sourced from vital registrations. Data linkage between ART, birth and perinatal death registers would improve the completeness and validity of the death data as well as providing information on the cause of death.
There are a number of limitations of a study where only the rates of perinatal mortality are reported. The inability to identify and exclude deaths due to lethal congenital anomalies and termination of pregnancy has particular implications for perinatal mortality reporting. Cause of death data should be incorporated into routine reporting of perinatal mortality to allow the analysis of risk factors and of clinical and institutional factors, with the aim of preventing future deaths. The study did not adjust for all major sociodemographic, institutional or clinical risk factors but was able to adjust for other major risk factors (number of embryos transferred, parity, female infertility and maternal age). It confirms that the number of embryos transferred is a modifiable risk factor for perinatal mortality in ART treatment. Although this study could adjust for number of ETs, it was unable to determine the risk of perinatal mortality for a woman having two consecutive SET births compared with one DET twin birth.
This population-based study provides evidence SET is associated with significantly lower rates of fetal and neonatal mortality compared with DET. From a public health perspective, there is justification for advocating SET as first-line management in ART with the aim of minimizing preventable perinatal deaths (Norman, 2011) . SET is also associated with very high rates of perinatal mortality for twin gestations. Further research is needed on the risk or predictive factors of single embryo twinning to minimize this outcome in the future.
